002399 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
002399 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company